腹腔镜与开腹脾切除术治疗脾大:结论尚不明确
本研究回顾性分析1997至2017年间491例择期脾切除术,对脾重500-1000g(中度脾大)和>1000g(重度脾大)患者按1:2匹配腹腔镜与开腹手术。结果显示腹腔镜组手术时间更长,重度脾大组再入院率更高,其他围术期结局与开腹组相当,腹腔镜未见明确获益。
要点
- 中度脾大(500-1000g)腹腔镜手术时间更长(178 vs 107 min),但住院时间和出血量相似。
- 重度脾大(>1000g)腹腔镜手术时间更长(171 vs 112 min),再入院率更高(27% vs 6%)。
- 腹腔镜治疗脾大的获益尚需进一步明确,目前证据未显示优于开腹手术。
核心结论
- 腹腔镜脾切除术治疗中度和重度脾大与更长的手术时间相关,其他围术期结局与开腹手术相当,未显示明确获益。
研究设计与样本
- 单中心回顾性研究,纳入1997至2017年491例择期脾切除术,其中268例脾重>500g。
- 中度脾大定义为脾重500-1000g,重度脾大定义为>1000g。
- 按腹腔镜:开腹=1:2匹配,中度脾大匹配22例腹腔镜和44例开腹,重度脾大匹配26例腹腔镜和52例开腹。
主要发现
- 中度脾大:腹腔镜组平均手术时间178分钟 vs 开腹组107分钟(p<0.01),住院时间和出血量相似。
- 重度脾大:腹腔镜组平均手术时间171分钟 vs 开腹组112分钟(p<0.01),再入院率27% vs 6%(p<0.05)。
- 重度脾大腹腔镜中转开腹率35% vs 中度脾大14%,但差异无统计学意义(p=0.09)。
- 其他围术期并发症(感染、血栓栓塞、再手术、再入院)和死亡率在两组间无差异。
临床怎么用
- 对于中度或重度脾大,腹腔镜脾切除术可作为可行术式,但需权衡更长的手术时间和重度脾大更高的再入院率。
- 目前证据未显示腹腔镜优于开腹手术,术式选择应个体化。
局限性
- 回顾性单中心研究,样本量有限(中度脾大22例腹腔镜,重度脾大26例腹腔镜),可能存在选择偏倚。
- 匹配仅控制脾重,其他混杂因素可能影响结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The benefits of laparoscopic splenectomy (LS) over open splenectomy (OS) for normal-sized spleens have been well documented. However, the role of laparoscopy for moderate and massive splenomegaly is debated. METHODS: A retrospective review of patients undergoing elective splenectomy at one institution from 1997 to 2017 was conducted. Moderate and massive splenomegaly was defined as splenic weight of 500-1000 g and greater than 1000 g, respectively. We performed a 1:2 matching of laparoscopic to open splenectomy to control for differences in splenic weight. Differences in perioperative morbidity (infection, thromboembolism, reoperation, readmission), intraoperative factors (blood loss, operative time), length of stay, and mortality were examined. RESULTS: A total of 491 elective splenectomies were identified. 268 cases were for splenic weights greater than 500 g. After a 1:2 matching of LS:OS, we identified 22 LS and 44 matched OS for moderate splenomegaly. The LS group had longer mean operative times (178 vs. 107 min, p < 0.01), with similar length of stay and blood loss. For massive splenomegaly, 26 LS were identified and matched to 52 OS. LS had longer mean operative times (171 vs. 112 min, p < 0.01) and higher readmission rates (27% vs. 6%, p < 0.05). Other factors and outcomes did not differ between LS and OS for moderate or massive splenomegaly. The conversion rate for LS was higher for massive versus moderate splenomegaly, but was not statistically significant (35% vs. 14%, p = 0.09). CONCLUSIONS: LS for moderate and massive splenomegaly is associated with longer operative times. Other perioperative outcomes were comparable to OS, with no demonstrated benefits for LS. Although LS may be a feasible approach to moderate and massive splenomegaly, its benefits require further clarification in this patient population.
引用
- Shin RD, Lis R, Levergood NR, et al. Laparoscopic versus open splenectomy for splenomegaly: the verdict is unclear. Surg Endosc. 2018. PMID: 30167946. doi:10.1007/s00464-018-6394-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。